The treatment of acute promyelocytic leukemia in 2023: Paradigm, advances, and future directions
The transformation of acute promyelocytic leukemia (APL) from an often fatal to highly curable cancer with long-term survival exceeding 90% is one of the greatest and most inspiring successes in oncology.A deeper understanding of the pathogenesis of APL heralded the introduction of highly effective 1160 therapies targeting the mutant protein that d